Anacor Pharmaceuticals Inc. | TalkMarkets

Latest Posts

Who Are The Next Acquisition Targets In Dermatology?

Article By: Ari Zoldan

Wednesday, March 22, 2017 8:25 AM EDT

Specialty pharmaceuticals is a highly dynamic sector with robust stock valuations and an active mergers & acquisition market. One of the most attractive areas for investment is dermatology.

In this article: IMNP, AZN, PFE, SNY, ANAC, RGEN, DERM, FOMX, LBTSF

Read

5 Biotech Takeover Targets That Could Get Bought Soon

Article By: Bret Jensen

Saturday, June 11, 2016 1:31 PM EDT

Don’t let the resurgence in M&A in the biotech sector pass you by. Bret Jensen shares his top five picks for likely acquisition targets in biotech.

In this article: AGN, AZN, PFE, SGYP, SNY, VRX, ACAD, ANAC, MDVN, PGNX, XNPT, BIIB, TEVA, ABBV, CPXX, IONS

Read

Healthcare Sector Is Looking A Tad Better: M&A Boosts Biotech…Update

Article By: Rod Raynovich

Tuesday, May 24, 2016 10:00 PM EDT

A broad rally today surprised many traders. Technology was a leader up 2% followed by healthcare up 1.49%. US new single family home sales hit an 8 year high a sign of growing prospects for the economy.

In this article: BMY, PFE, SNY, RHHBY, ALNY, ANAC, IBB, INCY, MDVN, QQQ, SGEN, BIIB, GILD, XBI, XLV, ABBV, GLYC, XON

Read

The Re-balancing - Financial Review

Article By: Marvin R Clark

Monday, May 16, 2016 10:30 PM EDT

The weaker dollar makes imports, including oil, more expensive, and the higher prices tend to spread through the broader economy. A sluggish April jobs report still leaves a June rate hike on the table.